OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001575659

Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc. (CIK 0001575659, EIN 46-2111820) reported revenue of $0 for FY2022 (2022-01-01 to 2022-12-31) and net income of -$1.79 million (-$1,794,726) for FY2022 (2022-01-01 to 2022-12-31), as filed in its 10-K filed 2023-03-30 (accession 0001393905-23-000156).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001575659
EIN46-2111820
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationNV
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_6qpmt2v8byt64p5dpzbwwbjv2g
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0FY20222022-01-01 to 2022-12-3110-K2023-03-300001393905-23-000156Revenues
Net income-$1,794,726FY20222022-01-01 to 2022-12-3110-K2023-03-300001393905-23-000156ProfitLoss
Total assets$2,254,580FY2022as of 2022-12-3110-K2023-03-300001393905-23-000156Assets
Total liabilities$5,396,063FY2022as of 2022-12-3110-K2023-03-300001393905-23-000156Liabilities
Stockholders' equity-$3,141,483FY2022as of 2022-12-3110-K2023-03-300001393905-23-000156StockholdersEquity
Operating cash flow-$1,151,709FY20222022-01-01 to 2022-12-3110-K2023-03-300001393905-23-000156NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.02 per shareFY20212021-01-01 to 2021-12-3110-K2022-03-160001393905-22-000069EarningsPerShareBasicAndDiluted
Shares outstanding7,881,567 sharesFY2022as of 2023-03-3010-K2023-03-300001393905-23-000156EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2013-2022, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20222022-01-01 to 2022-12-31$010-K2023-03-300001393905-23-000156
RevenueFY20212021-01-01 to 2021-12-31$53410-K2023-03-300001393905-23-000156
RevenueFY20202019-04-01 to 2020-03-31$9,13910-K2020-06-290001393905-20-000203
RevenueFY20192018-04-01 to 2019-03-31$010-K2020-06-290001393905-20-000203
RevenueFY20182017-04-01 to 2018-03-31$010-K2019-07-090001393905-19-000220
RevenueFY20172016-04-01 to 2017-03-31$010-K2018-12-060001393905-18-000353
Net incomeFY20222022-01-01 to 2022-12-31-$1,794,72610-K2023-03-300001393905-23-000156
Net incomeFY20212021-01-01 to 2021-12-31-$2,867,88310-K2022-03-160001393905-22-000069
Net incomeFY20202019-04-01 to 2020-03-31-$624,58410-K2020-06-290001393905-20-000203
Net incomeFY20192018-04-01 to 2019-03-31-$348,84110-K2020-06-290001393905-20-000203
Net incomeFY20182017-04-01 to 2018-03-31-$2,552,91410-K2019-07-090001393905-19-000220
Net incomeFY20172016-04-01 to 2017-03-31-$21,61610-K2018-12-060001393905-18-000353
Net incomeFY20162015-04-01 to 2016-03-31-$12,02010-K2017-07-140001393905-17-000206

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2023-08-142023-06-300001393905-23-000312rtsl-20230630.htm
10-Q2023-05-122023-03-310001393905-23-000220rtsl-20230331.htm
10-K2023-03-302022-12-310001393905-23-000156rtsl-20221231.htm
10-Q2022-11-102022-09-300001393905-22-000447rtsl-20220930.htm
10-Q2022-08-122022-06-300001393905-22-000302rtsl-20220630.htm
10-Q2022-05-112022-03-310001393905-22-000151rtsl-20220331.htm
10-K2022-03-162021-12-310001393905-22-000069rtsl-20211231.htm
10-Q2021-11-102021-09-300001393905-21-000494rtsl-20210930.htm
10-Q2021-08-112021-06-300001393905-21-000369rtsl-20210630.htm
10-Q2021-05-142021-03-310001393905-21-000251rtsl-20210331.htm
10-Q2020-11-092020-09-300001393905-20-000316rtsl_10q.htm
10-K/A2020-08-272020-06-300001393905-20-000265rtsl_10ka.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001575659published by the sourcedata.sec.gov/submissions/CIK0001575659.json2026-10-21
Employer Identification Number (EIN) · US-EIN46-2111820published by the sourcedata.sec.gov/submissions/CIK0001575659.json2026-10-21

Former names

NameFromTo
Holly Brothers Pictures, Inc.2017-06-072020-01-21
PowerMedChairs2013-05-232017-05-09

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001575659.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001575659.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001575659" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001575659/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001575659/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1575659"}

On SEC EDGAR

About this data